TITLE

Review: Hormone replacement therapy may reduce the risk for death in younger but not older postmenopausal women

AUTHOR(S)
Salpeter, S.
PUB. DATE
January 2005
SOURCE
ACP Journal Club;Jan/Feb2005, Vol. 142 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports that hormone replacement therapy (HRT) may reduce the risk for death in younger but not older postmenopausal women. For all age groups combined, HRT does not reduce the risk for total mortality, CV death and cancer death, but reduces death from other causes. Of the 13 randomized controlled trials that included the older age group, HRT and control groups did not differ for total mortality, CV death or cancer death.
ACCESSION #
15851757

 

Related Articles

  • Clinical Briefs. Preboth, Monica // American Family Physician;3/1/2000, Vol. 61 Issue 5, p1555 

    Provides several clinical reports and guidelines. Practical policy statement on peri-menopausal and postmenopausal hormone replacement therapy; `Year-End 1998 Emergency Department Data from the Drug Abuse Warning Network,' issued by the Substance Abuse and Mental Health Services Administration;...

  • The National Randomised Trial of Hormone Replacement Therapy in Women with a History of Early Stage Breast Cancer. Marsden, Jo // Journal of the British Menopause Society;2001, Vol. 7 Issue 2, p52 

    The article reports on the establishment of a national randomized trial of hormone replace therapy in women with a history of early stage breast cancer in Great Britain. 3,000 women will be recruited in the trial. The trial is funded by the Cancer Research Campaign and NHS Research and...

  • Hormone Replacement Therapy in Postmenopausal Women. Bush, Nancy Jo; Griffin-Sobel, Joyce P. // Oncology Nursing Forum;Sep/Oct2003, Vol. 30 Issue 5, p747 

    Presents a medical case study regarding hormone replacement therapy (HRT) to prevent in women. Risk for breast cancer; Findings of clinical trials regarding the risk and benefits of HRT; Alternative to systemic hormone replacement therapy to help prevent postmenopausal conditions and relieve...

  • CANCER. PARK, ALICE // Time International (South Pacific Edition);2/14/2011, Vol. 177 Issue 6, p18 

    The article discusses a large British clinical trial of breast-cancer risk in menopausal women who use combination estrogen-and-progestin pills and estrogen-only pills for hormone therapy.

  • WHI: 11-year follow-up of breast cancer incidence and mortality.  // Reactions Weekly;11/6/2010, Issue 1326, p1 

    The article reports on the results from an 11-year follow-up of the Women's Health Initiative (WHI) trial aimed to determine the incidence and mortality of breast cancer in postmenopausal women who received combined hormone therapy.

  • CANCER. PARK, ALICE // Time;2/14/2011, Vol. 177 Issue 6, p18 

    The article discusses a large British clinical trial of breast-cancer risk in menopausal women who use combination estrogen-and-progestin pills and estrogen-only pills for hormone therapy.

  • Controlled trials confirm HRT risks.  // Formulary;Nov2002, Vol. 37 Issue 11, p565 

    Discusses the findings of controlled clinical trials confirming the risk of hormone replacement therapy for fatal adverse events. Risk for breast cancer, stroke and pulmonary embolism; Placebo-controlled trials; Health of post-menopausal women.

  • NIH Workshop Tries to Create Consensus on HRT Use. Randal, Judith // JNCI: Journal of the National Cancer Institute;Jan2003, Vol. 95 Issue 1, p9 

    Reports on the workshop held by the U.S. National Institutes of Health to address issues arising from a clinical trial of Prempro, a estrogen-progestin used in hormone replacement therapy (HRT) for menopause. Average of women in the trial; Cardiovascular risk of HRT; Risk of injury from HRT.

  • Oestrogen therapy and endometrial center.  // British Medical Journal;7/23/1977, Vol. 2 Issue 6081, p209 

    Reports the use of hormone replacement therapy (HRT) to treat menopausal symptoms. Side effects of HRT; Association between long-term oestrogen therapy and endometrial carcinoma; Reference of HRT as conducive to the development of endometrial carcinoma.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics